Please login to the form below

Not currently logged in
Email:
Password:

Pegasus joins Ashfield Healthcare Communications

Acquired by UDG Healthcare in “strategically important” £16.8m deal
Pegasus joins Ashfield Healthcare Communications

From left: Simon Hackett, Lisa Bradley, Viv Adshead and David Moore

UK healthcare consultancy Pegasus has been bought by UDG Healthcare in a deal valued at up to £16.8m.

Pegasus becomes part of Ashfield Healthcare Communications, a subsidiary of UDG Healthcare's Ashfield Commercial and Medical Services Division, and will be under the leadership of its director David Moore.

Moore said that the acquisition of the healthcare consultancy is “strategically important” for the outsourced services provider.

“It strengthens our existing communications offering and broadens our capabilities in patient and consumer communications programmes, as well as corporate reputation and crisis management for our growing client base,” he added.

Pegasus is one of the UK's largest consumer healthcare-focused PR firms, with a team of 100 employees based in Brighton. Current clients include Daiichi Sankyo, Denplan, DuPont, Lloyds Pharmacy and Novo Nordisk.

Deputy managing director Simon Hackett becomes managing director, while Pegasus' founder Lisa Bradley will become the agency's chairman, taking over from Tim Adams who is departing.

Bradley commented: “Joining Ashfield will increase the breadth and depth of services we offer to our clients and will provide staff with the opportunity to acquire new skills.

“We know they are the right cultural fit for our agency and they share our passion for delivering innovative campaigns across healthcare.”

Article by
Rebecca Clifford

24th May 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics